A detailed history of General Atlantic LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, General Atlantic LLC holds 1,500,000 shares of RPRX stock, worth $37.4 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
1,500,000
Previous 1,500,000 -0.0%
Holding current value
$37.4 Million
Previous $39.6 Million 7.28%
% of portfolio
1.21%
Previous 1.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

BUY
$44.5 - $52.11 $66.8 Million - $78.2 Million
1,500,000 New
1,500,000 $72.8 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track General Atlantic LLC Portfolio

Follow General Atlantic LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Atlantic LLC, based on Form 13F filings with the SEC.

News

Stay updated on General Atlantic LLC with notifications on news.